XML 50 R28.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Schedule of Effective Income Tax Rate Reconciliation

A reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate is as follows:

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Federal statutory income tax rate

 

 

(21.0

)%

 

 

(21.0

)%

State taxes, net of federal benefit

 

 

(2.9

)

 

 

(1.7

)

Federal and state research and development tax

   credits

 

 

(4.0

)

 

 

(3.4

)

Nondeductible stock compensation

 

 

1.4

 

 

 

0.5

 

IPR&D expense

 

 

-

 

 

 

12.3

 

IRC Section 382 limit on attributes

 

 

(0.1

)

 

 

26.4

 

Other items

 

 

0.5

 

 

 

1.2

 

Increase in deferred tax asset valuation

   allowance

 

 

26.1

 

 

 

(14.3

)

Effective income tax rate

 

 

0.0

%

 

 

0.0

%

Schedule of Deferred Tax Assets

Net deferred tax assets as of December 31, 2021 and 2020 consisted of the following (in thousands):

 

 

 

December 31,

 

 

 

2021

 

 

2020

 

Deferred tax assets (liabilities):

 

 

 

 

 

 

 

 

Net operating loss carryforwards

 

$

30,147

 

 

$

13,618

 

Research and development and investment tax

   credits

 

 

3,719

 

 

 

856

 

Accrued expenses

 

 

734

 

 

 

374

 

Capitalized start-up costs

 

 

63

 

 

 

76

 

Capitalized research and development expense

 

 

8,529

 

 

 

10,317

 

Operating lease right-of-use assets

 

 

(703

)

 

 

(1,260

)

Operating lease liabilities

 

 

800

 

 

 

1,421

 

Contingent consideration

 

 

862

 

 

 

928

 

Stock compensation

 

 

2,257

 

 

 

1,149

 

Other

 

 

279

 

 

 

320

 

Total deferred tax assets

 

 

46,687

 

 

 

27,799

 

Valuation allowance

 

 

(46,687

)

 

 

(27,799

)

Net deferred tax assets

 

$

 

 

$

 

Changes in Valuation Allowance for Deferred Tax Assets

Changes in the valuation allowance for deferred tax assets during the year ended December 31, 2021 related primarily to the operating losses occurring during the year. Changes in the valuation allowance for deferred tax assets during the year ended December 31, 2020 related primarily to the decrease in net operating loss carryforwards and research and development tax credit carryforwards as a result of the limitation under Section 382 and were as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Valuation allowance as of beginning of year

 

$

27,799

 

 

$

38,487

 

Decreases recorded as benefit to income tax

   provision

 

 

 

 

 

(10,688

)

Increases recorded to income tax provision

 

 

18,888

 

 

 

 

Valuation allowance as of end of year

 

$

46,687

 

 

$

27,799